These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34310074)

  • 21. Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations.
    Di Tommaso C; Como C; Gurny R; Möller M
    Eur J Pharm Sci; 2010 Apr; 40(1):38-47. PubMed ID: 20184955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of critical process and formulation parameters affecting in-process stability of lactate dehydrogenase during the secondary drying stage of lyophilization: a mini freeze dryer study.
    Luthra S; Obert JP; Kalonia DS; Pikal MJ
    J Pharm Sci; 2007 Sep; 96(9):2242-50. PubMed ID: 17621675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation Screening and Freeze-Drying Process Optimization of Ginkgolide B Lyophilized Powder for Injection.
    Liu D; Galvanin F; Yu Y
    AAPS PharmSciTech; 2018 Feb; 19(2):541-550. PubMed ID: 28849380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular vesicles protect glucuronidase model enzymes during freeze-drying.
    Frank J; Richter M; de Rossi C; Lehr CM; Fuhrmann K; Fuhrmann G
    Sci Rep; 2018 Aug; 8(1):12377. PubMed ID: 30120298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of storage conditions stabilizing extracellular vesicles preparations.
    Görgens A; Corso G; Hagey DW; Jawad Wiklander R; Gustafsson MO; Felldin U; Lee Y; Bostancioglu RB; Sork H; Liang X; Zheng W; Mohammad DK; van de Wakker SI; Vader P; Zickler AM; Mamand DR; Ma L; Holme MN; Stevens MM; Wiklander OPB; El Andaloussi S
    J Extracell Vesicles; 2022 Jun; 11(6):e12238. PubMed ID: 35716060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
    Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
    J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability.
    Ramos Yacasi GR; Calpena Campmany AC; Egea Gras MA; Espina García M; García López ML
    Drug Dev Ind Pharm; 2017 Apr; 43(4):637-651. PubMed ID: 28044462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cryoprotectants on freezing, lyophilization, and storage of lyophilized recombinant alpha 1-antitrypsin formulations.
    Vemuri S; Yu CD; Roosdorp N
    PDA J Pharm Sci Technol; 1994; 48(5):241-6. PubMed ID: 8000898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
    Horn J; Schanda J; Friess W
    Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Freeze-drying of nanoparticles: How to overcome colloidal instability by formulation and process optimization.
    Trenkenschuh E; Friess W
    Eur J Pharm Biopharm; 2021 Aug; 165():345-360. PubMed ID: 34052428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant Drying Time Reduction Using Microwave-Assisted Freeze-Drying for a Monoclonal Antibody.
    Gitter JH; Geidobler R; Presser I; Winter G
    J Pharm Sci; 2018 Oct; 107(10):2538-2543. PubMed ID: 29890173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery.
    Ngamcherdtrakul W; Sangvanich T; Reda M; Gu S; Bejan D; Yantasee W
    Int J Nanomedicine; 2018; 13():4015-4027. PubMed ID: 30022824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid.
    Akers JC; Ramakrishnan V; Yang I; Hua W; Mao Y; Carter BS; Chen CC
    Cancer Biomark; 2016 Mar; 17(2):125-32. PubMed ID: 27062568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability and Function of Extracellular Vesicles Derived from Immortalized Human Corneal Stromal Stem Cells: A Proof of Concept Study.
    Lyu N; Knight R; Robertson SYT; Dos Santos A; Zhang C; Ma C; Xu J; Zheng J; Deng SX
    AAPS J; 2022 Dec; 25(1):8. PubMed ID: 36471035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stabilization of a recombinant human epidermal growth factor parenteral formulation through freeze-drying.
    Santana H; Sotolongo J; González Y; Hernández G; Chinea G; Gerónimo H; Amarantes O; Beldarraín A; Páez R
    Biologicals; 2014 Nov; 42(6):322-33. PubMed ID: 25190208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of a stable, freeze-dried virus-like particle-based vaccine formulation.
    Lang R; Winter G; Vogt L; Zurcher A; Dorigo B; Schimmele B
    Drug Dev Ind Pharm; 2009 Jan; 35(1):83-97. PubMed ID: 19016059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Formulation Composition and Process Settings of Traditional Batch Versus Continuous Freeze-Drying On Protein Aggregation.
    Vanbillemont B; Carpenter JF; Probst C; De Beer T
    J Pharm Sci; 2020 Nov; 109(11):3308-3318. PubMed ID: 32739274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of carbohydrate additives in the freeze-drying of alkaline phosphatase.
    Ford AW; Dawson PJ
    J Pharm Pharmacol; 1993 Feb; 45(2):86-93. PubMed ID: 8095538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.
    Li X; Thakkar SG; Ruwona TB; Williams RO; Cui Z
    J Control Release; 2015 Apr; 204():38-50. PubMed ID: 25735896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.